Role for primary immunosuppression with everolimus after pulmonary transplantation

Transpl Immunol. 2018 Aug:49:12-19. doi: 10.1016/j.trim.2018.03.005. Epub 2018 Mar 26.

¹ Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany. Electronic address: salman.jawad@mh-hannover.de.
² Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
³ Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.
⁴ Institute for Pathology, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.

No abstract available

Keywords: Cyclosporine A; Everolimus; Lung transplantation; Primary immunosuppression.

Publication types